As a consequence, only few DNA methylation biomarkers, such as KRT19, TNFRSF10D, CASP8, ZMYND10 and RASSF1A, were previously related with NB risk factors or survival [11,13-15,18,37-41]. The gene discussed is RASSF1; the disease is neuroblastoma.